Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
Rodríguez-Rodero S, Fernández AF, Fernández-Morera JL, Castro-Santos P, Bayon GF, Ferrero C, Urdinguio RG, Gonzalez-Marquez R, Suarez C, Fernández-Vega I, Fresno Forcelledo MF, Martínez-Camblor P, Mancikova V, Castelblanco E, Perez M, Marrón PI, Mendiola M, Hardisson D, Santisteban P, Riesco-Eizaguirre G, Matías-Guiu X, Carnero A, Robledo M, Delgado-Álvarez E, Menéndez-Torre E, Fraga MF. Rodríguez-Rodero S, et al. Among authors: hardisson d. J Clin Endocrinol Metab. 2013 Jul;98(7):2811-21. doi: 10.1210/jc.2012-3566. Epub 2013 May 10. J Clin Endocrinol Metab. 2013. PMID: 23666970
Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.
Peinado H, Moreno-Bueno G, Hardisson D, Pérez-Gómez E, Santos V, Mendiola M, de Diego JI, Nistal M, Quintanilla M, Portillo F, Cano A. Peinado H, et al. Among authors: hardisson d. Cancer Res. 2008 Jun 15;68(12):4541-50. doi: 10.1158/0008-5472.CAN-07-6345. Cancer Res. 2008. PMID: 18559498
Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation: a clinicopathologic study of 5 cases and review of the literature.
Mariño-Enríquez A, González-Rocha T, Burgos E, Stolnicu S, Mendiola M, Nogales FF, Hardisson D. Mariño-Enríquez A, et al. Among authors: hardisson d. Hum Pathol. 2008 Nov;39(11):1606-13. doi: 10.1016/j.humpath.2008.03.005. Epub 2008 Jul 11. Hum Pathol. 2008. PMID: 18620731 Review.
Angiogenesis and ovarian cancer.
Gómez-Raposo C, Mendiola M, Barriuso J, Casado E, Hardisson D, Redondo A. Gómez-Raposo C, et al. Among authors: hardisson d. Clin Transl Oncol. 2009 Sep;11(9):564-71. doi: 10.1007/s12094-009-0406-y. Clin Transl Oncol. 2009. PMID: 19775995 Review.
The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients.
Leskelä S, Leandro-García LJ, Mendiola M, Barriuso J, Inglada-Pérez L, Muñoz I, Martínez-Delgado B, Redondo A, de Santiago J, Robledo M, Hardisson D, Rodríguez-Antona C. Leskelä S, et al. Among authors: hardisson d. Endocr Relat Cancer. 2010 Dec 21;18(1):85-95. doi: 10.1677/ERC-10-0148. Print 2011 Feb. Endocr Relat Cancer. 2010. PMID: 21051560
Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Oaknin A, Guarch R, Barretina P, Hardisson D, González-Martín A, Matías-Guiu X, Pérez-Fidalgo A, Vieites B, Romero I, Palacios J. Oaknin A, et al. Among authors: hardisson d. Clin Transl Oncol. 2018 Mar;20(3):274-285. doi: 10.1007/s12094-017-1719-x. Epub 2017 Aug 16. Clin Transl Oncol. 2018. PMID: 28815456
[Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Oaknin A, Guarch R, Barretina P, Hardisson D, González-Martín A, Matías-Guiu X, Pérez-Fidalgo A, Vieites B, Romero I, Palacios J. Oaknin A, et al. Among authors: hardisson d. Rev Esp Patol. 2018 Apr-Jun;51(2):84-96. doi: 10.1016/j.patol.2017.11.002. Epub 2018 Jan 17. Rev Esp Patol. 2018. PMID: 29602379 Spanish.
162 results